Harvey Walsh is a leading healthcare intelligence and patient outcomes agency successful across the NHS, Pharmaceutical and Medical Device Industries. We are totally patient centric. Everything we do is focussed around improving patient outcomes.
Harvey Walsh receives health data under licence from NHS Digital. NHS Digital has a record of all hospital admissions and outcomes called the Hospital Episode Statistics (HES) dataset, and they provide this data to us every month. The data we use is pseudonymised and non-identifiable; this means individuals cannot be identified from the data. These data are only processed for the purposes of understanding and improving outcomes for patients and the provision of healthcare on behalf of the NHS, medical device and pharmaceutical industry. We never give direct access to unprocessed HES data; rather we aggregate data at an organisational level, provide insights and build analytical tools. The data is held securely at a location conforming to both ISO27001 and the NHS Information Governance Toolkit standards and is destroyed appropriately when required
Our strength is our people
The Harvey Walsh team comprises a broad range of experience
from both NHS and Commercial backgrounds.
Each with many years experience in the healthcare industry, and at the heart of the internal and client facing teams.
Chris HodgsonManaging Director
Chris joined the pharmaceutical industry in 1992 working for GSK in a variety of sales and marketing roles. After ten years he went on to work for Quintiles as Business Development Director. Chris’s interest in Health Informatics began after working with Aintree University Hospital, creating decision support software designed to help GP’s follow NICE COPD guidelines. Now at Harvey Walsh, Chris believes that use of multiple data sources and the application of cutting edge information technology, is one of the best ways to improve healthcare today.Email Chris firstname.lastname@example.org
Mark EvansBusiness Development Manager
Mark began his career in the pharmaceutical industry in 1989 as a GP rep for Ciba Geigy. He then moved to Baxter Healthcare where her worked for 16 years in a variety of specialist therapies including transfusion medicine, immunology disorders and haemophilia where he led the introduction of Baxter’s first recombinant FVIII into the UK market. After Baxter, Mark moved into the world of healthcare informatics where he now works at Harvey Walsh. Here he helps his clients understand the complexities of NHS data and how to use it to support improved patient outcomes.Email Mark email@example.com
Sarah BrooksBusiness Development Manager
Sarah joined Harvey Walsh in 2014 having previously specialised in digital marketing and communications for the healthcare sector. Sarah is passionate about improving health outcomes and optimising patient care and believes that the solutions Harvey Walsh have to offer can help improve healthcare today, and in the future.Email Sarah firstname.lastname@example.org